Russell Investments Group
CSCI

Russell Investments Group’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Russell Investments Group’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-79
Closed -$23K – 3101
2019
Q2 		$23K Sell
79
-15
-16% -$5.29K ﹤0.01% 2790
2019
Q1 		$43K Buy
+94
New +$36.5K ﹤0.01% 2812

Other funds holding CSCI

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return

Russell Investments Group's CSCI Position: Q3 2019 in Review

Russell Investments Group sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q3 2019, closing a stake of 79 shares — an estimated $23K sold.

Russell Investments Group first reported a position in CSCI in Q1 2019 and held it in 2 quarters. The position peaked at $43K in Q1 2019. 26 funds tracked by Wall St. Rank hold CSCI as of Q3 2019.

  • Russell Investments Group reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Russell Investments Group sold 79 COSCIENS Biopharma Inc. Common Stock shares in Q3 2019, an estimated $23K.
  • Russell Investments Group first reported a position in COSCIENS Biopharma Inc. Common Stock in Q1 2019 and held it in 2 quarters.
  • Russell Investments Group's COSCIENS Biopharma Inc. Common Stock position peaked at $43K in Q1 2019.
  • 26 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2019.

Based on Russell Investments Group's 13F filing for Q3 2019, filed 1 Nov 2019.